Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.985 USD | +5.85% | +5.71% | +28.14% |
Evolution of the average Target Price on Oramed Pharmaceuticals Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Oramed Pharmaceuticals Inc.
Canaccord Genuity | |
HC Wainwright | |
Cantor Fitzgerald | |
Aegis Capital | |
National Securities |
EPS Revisions
- Stock
- Equities
- Stock Oramed Pharmaceuticals Inc. - Nasdaq
- Consensus Oramed Pharmaceuticals Inc.